#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA868091	F	Antitumor activity against H22 cells implanted in mouse at 30 mg/kg, ip	Mus musculus	13		organism-based format	Scientific Literature
2.	ALA868094	F	Antitumor activity against H22 cells implanted in mouse at 15 mg/kg, ip	Mus musculus	2		organism-based format	Scientific Literature
3.	ALA868095	F	Antitumor activity against H22 cells implanted in mouse at 60 mg/kg, ip	Mus musculus	2		organism-based format	Scientific Literature
4.	ALA867381	F	Antiproliferative activity against mouse H22 cells	Mus musculus	1		cell-based format	Scientific Literature
5.	ALA2049444	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as tumor growth inhibition at 0.2 mg/kg, iv administered on day 8 post-tumor injection for 7 days measured on day 16 relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
6.	ALA2049445	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as tumor growth inhibition at 5 mg/kg, iv administered on day 8 post-tumor injection for 7 days measured on day 16 relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
7.	ALA2049446	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as decrease in cell survival at 0.2 mg/kg, iv administered on day 8 post-tumor injection for 7 days measured on day 16 by hematoxylin and eosin staining relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
8.	ALA2049447	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as decrease in cell survival at 5 mg/kg, iv administered on day 8 post-tumor injection for 7 days measured on day 16 relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
9.	ALA2049448	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as median survival time at 0.2 mk/kg, iv administered 24 hrs post-tumor injection for 7 days (Rvb = 12.7 +/- 2.5 days)	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA2049449	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as median survival time at 5 mk/kg, iv administered 24 hrs post-tumor injection for 7 days (Rvb = 12.7 +/- 2.5 days)	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA2049450	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as median survival time at 0.2 mk/kg, iv administered 24 hrs post-tumor injection for 7 days relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA2049451	F	Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as median survival time at 5 mk/kg, iv administered 24 hrs post-tumor injection for 7 days relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA2049452	F	Antimetastatic activity against mouse H22 cells xenografted in Kunming mouse assessed as decrease in lung tumor burden at 0.2 mg/kg, iv administered on day 11 post-tumor injection for 7 days measured on day 18 relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA2050604	F	Antimetastatic activity against mouse H22 cells xenografted in Kunming mouse assessed as decrease in lung metastases nodus number at 5 mg/kg, iv administered on day 11 post-tumor injection for 7 days measured on day 18 by hematoxylin and eosin staining relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA2050605	F	Antimetastatic activity against mouse H22 cells xenografted in Kunming mouse assessed as decrease in lung metastasis focuses at 0.2 mg/kg, iv administered on day 11 post-tumor injection for 7 days measured on day 18 relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA2050606	F	Antimetastatic activity against mouse H22 cells xenografted in Kunming mouse assessed as decrease in lung metastasis focuses number at 5 mg/kg, iv administered on day 11 post-tumor injection for 7 days measured on day 18 by hematoxylin and eosin staining relative to vehicle treated control	Mus musculus	1		organism-based format	Scientific Literature
17.	ALA2050607	F	Antimetastatic activity against mouse H22 cells xenografted in Kunming mouse assessed as tumor weight at 0.2 mg/kg, iv administered on day 11 post-tumor injection for 7 days measured on day 18 (Rvb = 0.34 +/- 0.15 g)	Mus musculus	1		organism-based format	Scientific Literature
18.	ALA2050608	F	Antimetastatic activity against mouse H22 cells xenografted in Kunming mouse assessed as tumor weight at 5 mg/kg, iv administered on day 11 post-tumor injection for 7 days measured on day 18 (Rvb = 0.34 +/- 0.15 g)	Mus musculus	1		organism-based format	Scientific Literature
19.	ALA1810513	F	Antiproliferative activity against mouse H22 cells after 48 hrs by MTT assay	Mus musculus	22		cell-based format	Scientific Literature
20.	ALA948107	F	Antitumor activity in mouse xenografted with H22 cells assessed as inhibition of tumor growth at 30 mg/kg/day, ip after 10 days	Mus musculus	1		organism-based format	Scientific Literature